Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
Programme I -
Thursday, September 13th, 2012

16:00-22:00   Registration Desk

Friday, September 14th, 2012
07:30-08:30   Registration Desk
 
Welcome and Introduction
08:30-09:00 Sven Pålhagen (Stockholm, Sweden)
G. Bernhard Landwehrmeyer (Ulm, Germany)
Bea De Schepper (President of the EHA, Moerbeke-Waas, Belgium)
Antoni Montserrat Moliner (European Commission, DG Health)
 
Plenary Session I:
'A look ahead'
Chair: Gill Bates (London, UK)
 
09:00-09:30   Frequency of Huntington Disease - Greater than you think
Michael Hayden (Vancouver, Canada)
 
09:30-10:00   What are we really looking for in an HD drug?
Cristina Sampaio (Princeton, USA)
 
10:00-10:30   Care, coping and research in HD – the earlier the better!
Alexandra Dürr (Paris, France)
 
10:30-11:00   Tea/Coffee Break

Plenary Session II:
'Frontiers in biology and their relevance to Huntington's disease'

Chair: Christian Néri (Paris, France)
 
11:00-11:30   Longevity pathways and their relevance to human disease
Hugo Aguilaniu (Lyon, France)
 
11:30-12:00   RNA toxicity in poly-Q disorders
Włodzimierz J. Krzyżosiak (Poznan, Poland)
 
12:00-12:30   Post-translational modifications and proteolysis of huntingtin
Ray Truant (Hamilton, Canada)
 
Poster Viewing
Chairs: Juliana Bronzova (Noordwijk, The Netherlands), Jean-Marc Burgunder (Bern, Switzerland), Raymund Roos (Leiden, The Netherlands)
 
12:30-14:00   Poster Viewing & Guided Poster Tours
 
12:30-14:00   Buffet Style Lunch
 
Plenary Session III:
'Science practice at EHDN'
Chair: G. Bernhard Landwehrmeyer (Ulm, Germany)
 
14:00-14:15   Scientific strategy of EHDN: implementation
Joaquim Ferreira (Lisbon, Portugal),
Juliana Bronzova (Noorwijk, The Netherlands),
Michael Orth (Ulm, Germany)
 
14:15-15:00   Juvenile HD Working Group
Oliver Quarrell (Sheffield, UK)
Advanced HD Working Group
Katia Youssov (Creteil, France)
Animal studies on the effects of physiotherapy
Simon Brooks (Cardiff, UK)
Human physiotherapy studies
Monica Busse (Cardiff, UK)
 
Short Communications I:
'Scientific Presentations: 10’ and 5’ questions – selected from submissions'

Chair: Åsa Petersen (Lund, Sweden)
 
15:00-15:15   Default-mode network changes in preclinical Huntington´s disease
Michael Orth (Ulm, Germany)
 
15:15-15:30   Longitudinal functional and connectivity changes during working memory performance in HD
Nellie Georgiou-Karistianis (Clayton, Australia)
 
15:30-15:45   Better global and cognitive functioning for choreatic compared to hypokinetic-rigid HD
Ellen 't Hart (Leiden, The Netherlands)
 
15:45-16:00   Critical consideration of the criteria for the motor diagnosis of HD
Jane S. Paulsen (Iowa, USA)
 
16:00-16:30   Tea/Coffee Break
 
Plenary Session IV:
'Keynote Presentations'

Chair: Joaquim Ferreira (Lisbon, Portugal)
 
16:30-17:15   Update on stem cell research: clinical potentials
Patrik Brundin (Lund, Sweden)
 
17:15-18:00   Cognitive alterations in HD
Julie Stout (Melbourne, Australia)
 
Roundup I
18:00-18:30   Lessons of the day
Edward Wild (London, UK) and Jeff Carroll (Bellingham, USA)
 
EHDN Reception at the City Hall
18:30-19:00 Boat trip to the City Hall
 
19:00-22:00 EHDN welcome reception dinner at the City Hall Stockholm, hosted by the City of Stockholm and the County of Stockholm